Beyondspring Inc

General ticker "BYSI" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $66.2M

Beyondspring Inc follows the US Stock Market performance with the rate: 16.0%.

Estimated limits based on current volatility of 3.7%: low 1.58$, high 1.71$

Factors to consider:

  • Price in estimated range
  • Earnings for 18 months up through Q2 (+1 year) exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2022-12-31 to 2024-12-30

  • 2022-12-31 to 2023-12-31 estimated range: [0.88$, 2.40$]
  • 2023-12-31 to 2024-12-30 estimated range: [0.99$, 2.57$]

Financial Metrics affecting the BYSI estimates:

  • Negative: Non-GAAP EPS, $ of -0.85 <= 0.10
  • Negative: Operating profit margin, % of -96.50 <= 1.03
  • Negative: Operating cash flow per share per price, % of -38.85 <= 2.35
  • Negative: negative Net income
  • Negative: Industry earnings per price (median), % of -24.66 <= 1.31
  • Negative: 0 < Interest expense per share, $ of 0

Similar symbols

Short-term BYSI quotes

Long-term BYSI plot with estimates

Financial data

YTD 2020-12-31 2021-12-31 2022-12-31
Operating Revenue $0.18MM $1.35MM $1.35MM
Operating Expenses $64.39MM $67.59MM $38.59MM
Operating Income $-64.21MM $-66.24MM $-37.24MM
Non-Operating Income $0.39MM $1.60MM $1.12MM
Interest Expense $0.09MM $0.09MM $0.02MM
R&D Expense $41.79MM $36.89MM $25.58MM
Income(Loss) $-63.82MM $-64.64MM $-36.12MM
Taxes $-2.76MM $3.57MM $0.16MM
Profit(Loss) $-61.06MM $-68.21MM $-36.28MM
Stockholders Equity $88.34MM $26.68MM $-5.98MM
Assets $117.04MM $81.65MM $46.22MM
Operating Cash Flow $-43.74MM $-47.24MM $-27.46MM
Capital expenditure $0.05MM $2.84MM $0.03MM
Investing Cash Flow $-0.05MM $-20.41MM $17.56MM
Financing Cash Flow $117.83MM $0.00MM $3.43MM
Earnings Per Share* $-2.04 $-1.75 $-0.93

* EPS are Split Adjusted, recent splits may be reflected with a delay.